Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Changes in Stockholders??? Equity

v3.24.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning Balance (in shares) at Dec. 31, 2021   37,387,472      
Beginning Balance at Dec. 31, 2021 $ 24,071 $ 4 $ 125,479 $ (101,342) $ (70)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock warrants 72   72    
Exercise of common stock options (in shares)   55,191      
Exercise of common stock options 30   30    
Share-based compensation 2,112   2,112    
Foreign currency translation adjustment (370)       (370)
Net loss $ (24,449)     (24,449)  
Ending Balance (in shares) at Dec. 31, 2022 37,442,663 37,442,663      
Ending Balance at Dec. 31, 2022 $ 1,466 $ 4 127,693 (125,791) (440)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock and common stock warrants (in shares)   10,312,500      
Issuance of common stock and common stock warrants 38,067 $ 1 38,066    
Reclassification of common stock warrants 598   598    
Exercise of common stock warrants (in shares)   194,031      
Exercise of common stock options (in shares)   392,256      
Exercise of common stock options 355   355    
Share-based compensation 2,485   2,485    
Issuance of common stock for settlement of restricted stock units and stock awards (in shares)   272,264      
Foreign currency translation adjustment (479)       (479)
Net loss $ (19,171)     (19,171)  
Ending Balance (in shares) at Dec. 31, 2023 48,613,714 48,613,714      
Ending Balance at Dec. 31, 2023 $ 23,321 $ 5 $ 169,197 $ (144,962) $ (919)